Status:
NOT_YET_RECRUITING
Dengue - Sample Collection Study Pakistan
Lead Sponsor:
Abbott Rapid Dx
Collaborating Sponsors:
Aga Khan University
National University of Medical Sciences, Pakistan
Conditions:
Dengue
Eligibility:
All Genders
12+ years
Brief Summary
The objective of this study is to collect well-characterized serum and plasma specimens from confirmed dengue positive and dengue negative subjects to support dengue diagnostic products development.
Eligibility Criteria
Inclusion
- Age ≥12-years-old
- Individuals suspected or confirmed for active dengue, with dengue-consistent symptoms onset up to and including 10 days before enrolment in this trial.
Exclusion
- Subject has been vaccinated for dengue.
- Subject participates in an investigative drug, vaccine or medical device clinical study
- Participant is deemed unfit for the study by the Investigator
- Participant is unwilling or unable to provide informed consent
Key Trial Info
Start Date :
October 1 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 1 2026
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT07203183
Start Date
October 1 2025
End Date
April 1 2026
Last Update
October 2 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.